Pharmacy society has a hard time when returning Chinese ‘Valsaltan’ ingredients

In a process of exchanging drugs containing Valsartan ingredients with carcinogenic factors, pharmacies are having trouble with patients over calculating patient-sharing expenses.

According to the pharmacy society, because the government took an action to suspend sales and restrict prescription on some antihypertensives containing Valsartan ingredients with carcinogenic factors, pharmacies hav...